A few days ago Dr. Tony Fauci of the NIH told me he’s
“relieved” Congress provided funds to respond to the Zika virus so that
federally funded scientists didn’t have to
work on developing a vaccine .
Shortly after the World Health Organization declared Zika to be a public health emergency, the White House requested $1.9 billion in February for emergency funding. After about seven months of finger pointing over which party was actually blocking the funding, Congress provided $1.1 billion on Sept. 29—one day before the fiscal year ended.
Fauci told me back in July that he couldn’t recall another
situation in which Congress took this long to agree on funding a response to a
public health emergency. And this is a guy whose appointment in
1984 as director
of the National Institute of Allergy and Infectious Diseases in the
National Institutes of Health is about the same age as your average
millennial. So he’s overseen the agency’s response for Ebola, pandemic
influenza, not to mention the
And he and his colleagues within the Department of Health
and Human Services have made their disappointment clear. HHS organized several
press conferences this summer with groups like the March of Dimes and the
obstetrician’s association to call on Congress to support the emergency
request. Fauci said he can continue with vaccine work—“the most important” part
of the NIH’s response—
but his institute can’t pay back
any of the $34.2 million it took
from other institutes and centers to keep Zika work going.
Nicole Lurie, who heads up the medical countermeasures office said during
a press conference Oct. 3
“We had manufacturers walk away from
negotiations with us because they weren’t sure the money was going to be
there.” (Of course we reporters wanted to know who, but that is
procurement-sensitive intel). Plus while there are nine vaccine candidates in
the pipeline, Lurie said “we are behind where we should be” on vaccine
development as “manufacturers really couldn’t count on funds being there.”
But now that they have the money, HHS Secretary Sylvia Mathews Burwell said more vaccine candidates and tests to screen for the Zika virus are on the way.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)